ERBB2 and cancer: Several studies incorporated clinicopathological features directly related to BC, including age, cancer stage, grade, tumor size, estrogen receptor (ER) status, progesterone receptor (PR) status, and human epidermal growth factor receptor 2 (HER2) status.